Christian Leikert

Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany.

Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.

CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.

For more than a decade, Aegis Analytical has provided Enterprise Manufacturing Intelligence solutions that help leading companies such as Abbott Labs, Baxter, Biogen Idec, Cephalon, Eli Lilly, Genzyme, GlaxoSmithKline, Merck Serono and Talecris to realize manufacturing operations excellence. Aegis' Discoverant software solution helps process manufacturers access, aggregate, contextualize and analyze data on-demand from raw materials to final product in both production and process development environments. Discoverant enables customers to accelerate products to market, increase supply chain efficiencies, reduce the cost of new process start-up, quality compliance, improve process predictability and collaboration across captive or outsourced sites. By enabling a laser-like focus on the performance of the manufacturing process itself, Discoverant is the foundation of Enterprise Manufacturing Intelligence and a critical application for initiatives such as Tech Transfer, CMC, Lean, Six Sigma, Continuous Quality Verification and Supply Chain Efficiency.

CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.